Excited to share our new bioRxiv preprint!
We present GepiClock, an epigenetic clock trained on cancer methylomes predicting age in both cancer and normal samples outperforming previous clocks. Applied to cancer cell lines, it reveals age-linked gene dependencies and drug response vulnerabilities.
